Project Profile: MBC BioLab

MBC Biolabs2020-09-13T09:32:12-07:00August 18th, 2020|In the Media|

August 2020

MBC Biolabs2024-10-06T14:56:50-07:00August 13th, 2020|Newsletters 2020|

XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI

MBC Biolabs2020-08-18T19:26:06-07:00August 4th, 2020|Startup News|

Servier Golden Ticket 2020

MBC Biolabs2022-04-06T19:45:02-07:00July 30th, 2020|2020, Servier Golden Ticket|

Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection

MBC Biolabs2020-08-18T18:49:06-07:00July 23rd, 2020|Startup News|

July 2020

MBC Biolabs2024-10-06T14:54:29-07:00July 16th, 2020|Newsletters 2020|

With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseases

MBC Biolabs2020-08-11T16:46:10-07:00July 13th, 2020|Startup News|

Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases

MBC Biolabs2020-08-18T19:36:18-07:00July 9th, 2020|Startup News|

Biotech startup announces R&D collaboration with major Japanese drug delivery company

MBC Biolabs2020-08-11T16:47:30-07:00July 7th, 2020|Startup News|

BioWorld: Drug developers’ Golden Ticket

MBC Biolabs2020-07-03T18:29:49-07:00July 2nd, 2020|MBC Biolabs News|